Search results for "Infectious Diseases"
Mixed results for remdesivir, negative results for canakinumab, and new vaccine information
Remdesivir appeared to be of benefit in one study but was associated with increased length of stay and no improvement in survival in another, an industry-funded trial found no benefit for canakinumab in severe COVID-19, and the FDA noted a possible increased risk for Guillain-Barré syndrome with the Johnson & Johnson (Janssen) vaccine.
https://acphospitalist.acponline.org/weekly/archives/2021/07/21/1.htm
21 Jul 2021
Good news on IL-6 inhibitors for COVID-19, bad news on other drugs, effects of surge
The NIH updated its guidelines; recent research looked at interleukin-6 (IL-6) inhibitors, ivermectin, remdesivir, and hydroxychloroquine in COVID-19; and one study estimated that 23.2% of inpatient COVID-19 deaths last spring and summer could relate to hospital strain.
https://acphospitalist.acponline.org/weekly/archives/2021/07/14/1.htm
14 Jul 2021
Guidelines suggest fidaxomicin over vancomycin for Clostridioides difficile infection
The Infectious Diseases Society of America and Society for Healthcare Epidemiology of America made three new recommendations in a focused update of their guidelines on Clostridioides difficile infection.
https://acphospitalist.acponline.org/weekly/archives/2021/06/30/4.htm
30 Jun 2021
New EUA and dose guidelines for COVID-19 released, ACIP reviewed myocarditis reports
The FDA gave an emergency use authorization (EUA) to tocilizumab for inpatients, the NIH revised dosing recommendations on monoclonal antibodies for outpatients, and government experts said myocarditis is extremely rare with the vaccines, among other recent COVID-19 news.
https://acphospitalist.acponline.org/weekly/archives/2021/06/30/1.htm
30 Jun 2021
Latest COVID-19 research focuses on another drug, racial disparities, early infections
A Brazilian trial found benefit from tofacitinib in hospitalized patients, while a study of Medicare patients showed racial disparities might stem from differences between hospitals.
https://acphospitalist.acponline.org/weekly/archives/2021/06/23/1.htm
23 Jun 2021
Preop meds, resuscitation champions, and more
Research summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2021/06/in-the-news.htm
15 Jun 2021
Diuretic guidance, endocarditis risks, and more
Research summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2021/06/recent-research.htm
15 Jun 2021
New research adds to data on symptoms after COVID-19, vaccines' effects
Several COVID-19 studies looked at persistent symptoms, while new vaccine research found limited antibody responses in some patients and advised on tests for clotting complications. Other studies quantified the target population for tocilizumab treatment and gender differences in infections.
https://acphospitalist.acponline.org/weekly/archives/2021/05/26/1.htm
26 May 2021
Fighting HAIs while fighting a pandemic
Central line-associated bloodstream infections made a comeback last year.
https://acphospitalist.acponline.org/archives/2021/05/fighting-hais-while-fighting-a-pandemic.htm
15 May 2021
Late diagnoses, routine cultures, and more
Research summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2021/05/recent-research.htm
15 May 2021